TY - JOUR T1 - Sergliflozin, a Novel Selective Inhibitor of Low Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther DO - 10.1124/jpet.106.110296 AU - Kenji Katsuno AU - Yoshikazu Fujimori AU - Yukiko Takemura AU - Masahiro Hiratochi AU - Fumiaki Itoh AU - Yoshimitsu Komatsu AU - Hideki Fujikura AU - Masayuki Isaji Y1 - 2006/10/18 UR - http://jpet.aspetjournals.org/content/early/2006/10/18/jpet.106.110296.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -